MetaVia Inc (MTVA)
1.62
-0.01
(-0.61%)
USD |
NASDAQ |
Dec 24, 16:00
MetaVia Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Dermata Therapeutics Inc | -- |
| Cognition Therapeutics Inc | 0.00 |
| ZyVersa Therapeutics Inc | -- |
| Cytokinetics Inc | -45.05M |
| Ocugen Inc | -0.507M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.589M |
| Cash from Financing (Quarterly) | -0.676M |
| Free Cash Flow | -22.69M |
| Free Cash Flow Per Share (Quarterly) | -0.5472 |
| Free Cash Flow Yield | -217.0% |